Molecules 2008, 13(5), 1081-1110; doi:10.3390/molecules13051081
Article

Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization

Marcel Holzer 1, Sigrid Ziegler 1, Beatrice Albrecht 1, Bernd Kronenberger 1, Artur Kaul 2, Ralf Bartenschlager 2, Lars Kattner 3, Christian D. Klein 1 and Rolf W. Hartmann 1,* email
1 Pharmaceutical and Medicinal Chemistry, Saarland University, PO Box 151150, D-66041 Saarbrücken, Germany 2 Department of Molecular Virology, University of Heidelberg, Im Neuenheimer Feld 345, D-69120 Heidelberg, Germany 3 Endotherm GmbH, Science-Park II, D-66123 Saarbrücken, Germany
* Author to whom correspondence should be addressed.
Received: 26 March 2008; in revised form: 2 May 2008 / Accepted: 7 May 2008 / Published: 7 May 2008
PDF Full-text Download PDF Full-Text [182 KB, uploaded 1 October 2008 09:18 CET]
Abstract: Terfenadine (4-[4-(hydroxydiphenylmethyl)-1-piperidyl]-1-(4-tert-butylphenyl)-butan-1-ol) was identified in a biological screening to be a moderate inhibitor (27% inhibition) of the CD81-LEL–HCV-E2 interaction. To increase the observed biologicalactivity, 63 terfenadine derivates were synthesized via microwave assisted nucleophilicsubstitution. The prepared compounds were tested for their inhibitory potency by means ofa fluorescence labeled antibody assay using HUH7.5 cells. Distinct structure-activityrelationships could be derived. Optimization was successful, leading to 3g, identfied as themost potent compound (69 % inhibition). Experiments with viral particles revealed thatthere might be additional HCV infection reducing mechanisms.
Keywords: Hepatitis C Virus; CD81-receptor; large extracellular loop; terfenadine derivatives; microwave assisted syntheses.

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Holzer, M.; Ziegler, S.; Albrecht, B.; Kronenberger, B.; Kaul, A.; Bartenschlager, R.; Kattner, L.; Klein, C.D.; Hartmann, R.W. Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization. Molecules 2008, 13, 1081-1110.

AMA Style

Holzer M., Ziegler S., Albrecht B., Kronenberger B., Kaul A., Bartenschlager R., Kattner L., Klein C.D., Hartmann R.W. Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization. Molecules. 2008; 13(5):1081-1110.

Chicago/Turabian Style

Holzer, Marcel; Ziegler, Sigrid; Albrecht, Beatrice; Kronenberger, Bernd; Kaul, Artur; Bartenschlager, Ralf; Kattner, Lars; Klein, Christian D.; Hartmann, Rolf W. 2008. "Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization." Molecules 13, no. 5: 1081-1110.

Molecules EISSN 1420-3049 Published by MDPI Publishing, Basel, Switzerland RSS E-Mail Table of Contents Alert